Dillon & Associates Inc
- SEC CIK
- 0001054425
- Latest filing
- Aug 5, 2026
IBRX holding history
ImmunityBio, Inc. in every 13F filed by Dillon & Associates Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IBRX overviewAll 13F holders of IBRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 23,800
- Value
- $214.0K
- % of portfolio
- <0.1%
- Quarters held
- 5
- Since Q2 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 23,800 | $214.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 23,800 | $190.0K | <0.1% | −2,000−7.8% | Reduced | Holders |
| Q4 2025 | 25,800 | $52.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 25,800 | $52.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 25,800 | $77.0K | <0.1% | +25,800 | New | Holders |